Takaisin Tulosta

Pakko-oireinen häiriö (OCD), näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
24.1.2023

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Pakko-oireinen häiriö (OCD) «Pakko-oireinen häiriö (OCD)»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Acevedo N, Bosanac P, Pikoos T ym. Therapeutic Neurostimulation in Obsessive-Compulsive and Related Disorders: A Systematic Review. Brain Sci 2021;11: «PMID: 34356182»PubMed
  2. Afshar H, Akuchekian S, Mahaky B ym. Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial. J Res Med Sci 2014;19:976-81 «PMID: 25538783»PubMed
  3. Andrade C. Augmentation With Memantine in Obsessive-Compulsive Disorder. J Clin Psychiatry 2019;80: «PMID: 31846244»PubMed
  4. Askari S, Mokhtari S, Shariat SV ym. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. BMC Psychiatry 2022;22:34 «PMID: 35022014»PubMed
  5. Bation R, Mondino M, Le Camus F ym. Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial. Eur Psychiatry 2019;62:38-44 «PMID: 31525581»PubMed
  6. Berlin HA, Koran LM, Jenike MA ym. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2011;72:716-21 «PMID: 20816027»PubMed
  7. Bloch MH, McGuire J, Landeros-Weisenberger A ym. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2010;15:850-5 «PMID: 19468281»PubMed
  8. Bloch MH, Wasylink S, Landeros-Weisenberger A ym. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry 2012;72:964-70 «PMID: 22784486»PubMed
  9. Bruno A, Micò U, Pandolfo G ym. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. J Psychopharmacol 2012;26:1456-62 «PMID: 22351381»PubMed
  10. Brunoni AR, Moffa AH, Sampaio-Junior B ym. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. N Engl J Med 2017;376:2523-2533 «PMID: 28657871»PubMed
  11. Chien WT, Tse MK, Chan HY, Cheng HY, Chen L. Is mindfulness-based intervention an effective treatment for people with obsessive-compulsive disorder? A systematic review and meta-analysis. J Obsessive Compuls Relat Disord 2022;32; 100712.
  12. Couto JP, Moreira R. Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 2018;86:245-254 «PMID: 29908912»PubMed
  13. Crockett BA, Churchill E, Davidson JR. A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry 2004;16:127-32 «PMID: 15517844»PubMed
  14. Davíðsdóttir SD, Sigurjónsdóttir Ó, Ludvigsdóttir SJ ym. Implementation of the Bergen 4-Day Treatment for Obsessive Compulsive Disorder in Iceland. Clin Neuropsychiatry 2019;16:33-38 «PMID: 34908936»PubMed
  15. de Boer JN, Vingerhoets C, Hirdes M ym. Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis. Psychiatry Res 2019;278:294-302 «PMID: 31254879»PubMed
  16. Dèttore D, Pozza A, Andersson G. Efficacy of technology-delivered cognitive behavioural therapy for OCD versus control conditions, and in comparison with therapist-administered CBT: meta-analysis of randomized controlled trials. Cogn Behav Ther 2015;44:190-211 «PMID: 25705787»PubMed
  17. Dold M, Aigner M, Lanzenberger R ym. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Int J Neuropsychopharmacol 2015;18: «PMID: 25939614»PubMed
  18. Donovan MR, Glue P, Kolluri S ym. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis. J Affect Disord 2010;123:9-16 «PMID: 19616306»PubMed
  19. Dos Santos-Ribeiro S, de Salles Andrade JB, Quintas JN ym. A Systematic Review of the Utility of Electroconvulsive Therapy in Broadly Defined Obsessive-Compulsive-Related Disorders. Prim Care Companion CNS Disord 2018;20: «PMID: 30407758»PubMed
  20. Elliott SJ, Marshall D, Morley K ym. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD). Cochrane Database Syst Rev 2021;9:CD013173 «PMID: 34693989»PubMed
  21. Emamzadehfard S, Kamaloo A, Paydary K ym. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study. Psychiatry Clin Neurosci 2016;70:332-41 «PMID: 27106362»PubMed
  22. Farnia V, Gharehbaghi H, Alikhani M ym. Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial. J Psychiatr Res 2018;104:137-143 «PMID: 30044966»PubMed
  23. Farrell LJ, Waters AM, Tiralongo E ym. Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial. Depress Anxiety 2022;39:461-473 «PMID: 35084071»PubMed
  24. Fatori D, de Bragança Pereira CA, Asbahr FR ym. Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial. J Anxiety Disord 2018;58:42-50 «PMID: 30025255»PubMed
  25. Ferrando, C., & Selai, C. (2021). A systematic review and meta-analysis on the effectiveness of exposure and response prevention therapy in the treatment of Obsessive-Compulsive Disorder. Journal of Obsessive-Compulsive and Related Disorders, 31, 100684. https://doi.org/10.1016/j.jocrd.2021.100684
  26. Fisher PL, Cherry MG, Stuart T ym. People with obsessive-compulsive disorder often remain symptomatic following psychological treatment: A clinical significance analysis of manualised psychological interventions. J Affect Disord 2020;275:94-108 «PMID: 32658831»PubMed
  27. Fitzsimmons SMDD, van der Werf YD, van Campen AD ym. Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis. J Affect Disord 2022;302:302-312 «PMID: 35041869»PubMed
  28. Fontenelle LF, Coutinho ES, Lins-Martins NM ym. Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review. J Clin Psychiatry 2015;76:949-57 «PMID: 25844888»PubMed
  29. Gadallah AA, Ebada MA, Gadallah A, Ahmed H, Rashad W, Eid KA, Bahbah E, Alkanj S. Efficacy and safety of N-acetylcysteine as add-on therapy in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis. Journal of Obsessive-Compulsive and Related Disorders 2020;25:100529.
  30. Geller DA, Biederman J, Stewart SE ym. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003;160:1919-28 «PMID: 14594734»PubMed
  31. Ghaleiha A, Entezari N, Modabbernia A ym. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res 2013;47:175-80 «PMID: 23063327»PubMed
  32. Gosmann NP, Costa MA, Jaeger MB ym. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. PLoS Med 2021;18:e1003664 «PMID: 34111122»PubMed
  33. Gowda SM, Narayanaswamy JC, Hazari N ym. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial. Brain Stimul 2019;12:922-929 «PMID: 30808612»PubMed
  34. Grant PJ, Joseph LA, Farmer CA ym. 12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology 2014;39:1453-9 «PMID: 24356715»PubMed
  35. Haghighi M, Jahangard L, Mohammad-Beigi H ym. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology (Berl) 2013;228:633-40 «PMID: 23525525»PubMed
  36. Hansen B, Hagen K, Öst LG ym. The Bergen 4-Day OCD Treatment Delivered in a Group Setting: 12-Month Follow-Up. Front Psychol 2018;9:639 «PMID: 29774005»PubMed
  37. Havnen A, Hansen B, Öst LG ym. Concentrated ERP Delivered in a Group Setting: A Replication Study. Behav Cogn Psychother 2017;45:530-536 «PMID: 28287064»PubMed
  38. Havnen, A., Hansen, B., Öst, L.-G., & Kvale, G. (2014). Concentrated ERP delivered in a group setting: An effectiveness study. Journal of Obsessive-Compulsive and Related Disorders, 3(4), 319–324. https://doi.org/10.1016/j.jocrd.2014.08.002
  39. Heidari M, Zarei M, Hosseini SM ym. Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder. Int Clin Psychopharmacol 2014;29:344-50 «PMID: 24850229»PubMed
  40. Heikman P, Katila H, Sarna S ym. Differential response to right unilateral ECT in depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945]. BMC Psychiatry 2002;2:2 «PMID: 11846888»PubMed
  41. Hollander E, Kaplan A, Stahl SM. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 2003;4:30-4 «PMID: 12582975»PubMed
  42. Hyde J, Carr H, Kelley N ym. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials. Mol Psychiatry 2022;27:2709-2719 «PMID: 35365806»PubMed
  43. Ivarsson T, Skarphedinsson G, Kornør H ym. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Psychiatry Res 2015;227:93-103 «PMID: 25769521»PubMed
  44. Kellner CH, Knapp RG, Petrides G ym. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006;63:1337-44 «PMID: 17146008»PubMed
  45. Khalkhali M, Aram S, Zarrabi H ym. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iran J Psychiatry 2016;11:104-14 «PMID: 27437007»PubMed
  46. Komossa K, Depping AM, Meyer M ym. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010;:CD008141 «PMID: 21154394»PubMed
  47. Kotapati VP, Khan AM, Dar S ym. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis. Front Psychiatry 2019;10:523 «PMID: 31447707»PubMed
  48. Kothari R, Barker C, Pistrang N ym. A randomised controlled trial of guided internet-based cognitive behavioural therapy for perfectionism: Effects on psychopathology and transdiagnostic processes. J Behav Ther Exp Psychiatry 2019;64:113-122 «PMID: 30981162»PubMed
  49. Kvale G, Hansen B, Björgvinsson T ym. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry 2018;18:323 «PMID: 30286745»PubMed
  50. Kyrios M, Ahern C, Fassnacht DB ym. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial. J Med Internet Res 2018;20:e242 «PMID: 30089607»PubMed
  51. Launes G, Hagen K, Sunde T ym. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment. Front Psychol 2019;10:2500 «PMID: 31803089»PubMed
  52. Launes G, Hagen K, Öst LG ym. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention. Front Psychol 2020;11:982 «PMID: 32528372»PubMed
  53. Liang K, Li H, Bu X ym. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Transl Psychiatry 2021;11:332 «PMID: 34050130»PubMed
  54. Maneeton N, Maneeton B, Karawekpanyawong N ym. Fluoxetine in acute treatment of children and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis. Nord J Psychiatry 2020;74:461-469 «PMID: 32242450»PubMed
  55. Miegel F, Moritz S, Hottenrott B, Demiralay C, Jelinek L. Metacognitive Training for Obsessive-Compulsive Disorder: A randomized controlled trial. J Obsessive Compuls Relat Disord 2021 Jul 1;30:100647.
  56. Modarresi A, Chaibakhsh S, Koulaeinejad N ym. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder. Psychiatry Res 2019;282:112602 «PMID: 31630042»PubMed
  57. Modarresi A, Sayyah M, Razooghi S ym. Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Pharmacopsychiatry 2018;51:263-269 «PMID: 29100251»PubMed
  58. Mowla A, Khajeian AM, Sahraian A ym. Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial. CNS Spectr 2010;15:613-7 «PMID: 24726048»PubMed
  59. Mutz J, Edgcumbe DR, Brunoni AR ym. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev 2018;92:291-303 «PMID: 29763711»PubMed
  60. Mutz J, Vipulananthan V, Carter B ym. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ 2019;364:l1079 «PMID: 30917990»PubMed
  61. Pagnin D, de Queiroz V, Pini S ym. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004;20:13-20 «PMID: 15087991»PubMed
  62. Pearcy CP, Anderson RA, Egan SJ ym. A systematic review and meta-analysis of self-help therapeutic interventions for obsessive-compulsive disorder: Is therapeutic contact key to overall improvement? J Behav Ther Exp Psychiatry 2016;51:74-83 «PMID: 26794856»PubMed
  63. Pellegrini L, Garg K, Enara A ym. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications. Compr Psychiatry 2022;118:152339 «PMID: 35917621»PubMed
  64. Perera MPN, Mallawaarachchi S, Miljevic A ym. Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Meta-analysis of Randomized, Sham-Controlled Trials. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:947-960 «PMID: 33775927»PubMed
  65. Petrides G, Fink M, Husain MM ym. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;17:244-53 «PMID: 11731725»PubMed
  66. Philip J, Cherian V. Acceptance and commitment therapy in the treatment of obsessive-compulsive disorder: A systematic review. J Obsessive Compuls Relat Disord 2021 Jan 1;28:100603.
  67. Pittenger C, Bloch MH, Wasylink S ym. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. J Clin Psychiatry 2015;76:1075-84 «PMID: 26214725»PubMed
  68. Rapinesi C, Kotzalidis GD, Ferracuti S ym. Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review. Curr Neuropharmacol 2019;17:787-807 «PMID: 30963971»PubMed
  69. Rehn S, Eslick GD, Brakoulias V. A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD). Psychiatr Q 2018;89:645-665 «PMID: 29423665»PubMed
  70. Reid JE, Laws KR, Drummond L ym. Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials. Compr Psychiatry 2021;106:152223 «PMID: 33618297»PubMed
  71. Rodriguez CI, Kegeles LS, Levinson A ym. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology 2013;38:2475-83 «PMID: 23783065»PubMed
  72. Sahraian A, Jahromi LR, Ghanizadeh A ym. Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Clin Psychopharmacol 2017;37:246-249 «PMID: 28099183»PubMed
  73. Sánchez-Meca J, Rosa-Alcázar AI, Iniesta-Sepúlveda M ym. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis. J Anxiety Disord 2014;28:31-44 «PMID: 24334214»PubMed
  74. Sarris J, Byrne G, Castle D ym. N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2022;117:110550 «PMID: 35304155»PubMed
  75. Schröder J, Werkle N, Cludius B ym. Unguided Internet-based cognitive-behavioral therapy for obsessive-compulsive disorder: A randomized controlled trial. Depress Anxiety 2020;37:1208-1220 «PMID: 33169490»PubMed
  76. Sharma LP, Thamby A, Balachander S ym. Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder. Asian J Psychiatr 2020;52:102183 «PMID: 32554207»PubMed
  77. Silva RMFD, Brunoni AR, Goerigk S ym. Efficacy and safety of transcranial direct current stimulation as an add-on treatment for obsessive-compulsive disorder: a randomized, sham-controlled trial. Neuropsychopharmacology 2021;46:1028-1034 «PMID: 33452434»PubMed
  78. Skapinakis P, Caldwell DM, Hollingworth W ym. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 2016;3:730-739 «PMID: 27318812»PubMed
  79. Skapinakis P, Papatheodorou T, Mavreas V. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol 2007;17:79-93 «PMID: 16904298»PubMed
  80. Soltani F, Sayyah M, Feizy F ym. A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder. Hum Psychopharmacol 2010;25:509-13 «PMID: 20737524»PubMed
  81. Soomro GM, Altman D, Rajagopal S ym. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008;2008:CD001765 «PMID: 18253995»PubMed
  82. Soomro GM. Obsessive compulsive disorder. BMJ Clin Evid 2012;2012: «PMID: 22305974»PubMed
  83. Storch EA, Goddard AW, Grant JE ym. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry 2013;74:e527-32 «PMID: 23842022»PubMed
  84. Storch EA, Wilhelm S, Sprich S ym. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2016;73:779-88 «PMID: 27367832»PubMed
  85. Taiminen T, Jääskeläinen SK. Sarjamagneettistimulaation mahdollisuudet psykiatriassa ja tulevaisuuden näkymät. Lääkärilehti 51-52/2020 vsk 75.
  86. Trevizol AP, Shiozawa P, Cook IA ym. Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. J ECT 2016;32:262-266 «PMID: 27327557»PubMed
  87. Uhre CF, Uhre VF, Lønfeldt NN ym. Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. J Am Acad Child Adolesc Psychiatry 2020;59:64-77 «PMID: 31589909»PubMed
  88. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361:799-808 «PMID: 12642045»PubMed
  89. van Diermen L, van den Ameele S, Kamperman AM ym. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry 2018;212:71-80 «PMID: 29436330»PubMed
  90. Wergeland GJH, Riise EN, Öst LG. Cognitive behavior therapy for internalizing disorders in children and adolescents in routine clinical care: A systematic review and meta-analysis. Clin Psychol Rev 2021;83:101918 «PMID: 33186776»PubMed
  91. Wootton BM, Karin E, Titov N ym. Self-guided internet-delivered cognitive behavior therapy (ICBT) for obsessive-compulsive symptoms: A randomized controlled trial. J Anxiety Disord 2019;66:102111 «PMID: 31301476»PubMed
  92. Xu J, Hao Q, Qian R ym. Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose-Response Meta-Analysis. Front Psychiatry 2021;12:717999 «PMID: 34630180»PubMed
  93. Yoosefee S, Amanat M, Salehi M ym. The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial. BMC Psychiatry 2020;20:570 «PMID: 33256659»PubMed
  94. Zhou DD, Wang W, Wang GM ym. An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder. J Affect Disord 2017;215:187-196 «PMID: 28340445»PubMed
  95. Zhou DD, Zhou XX, Li Y ym. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2019;90:277-287 «PMID: 30576763»PubMed
  96. Zhou DD, Zhou XX, Lv Z ym. Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis. J Psychiatr Res 2019;111:51-58 «PMID: 30677645»PubMed
  97. Zhou S, Fang Y. Efficacy of Non-Invasive Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Controlled Trials. Brain Sci 2022;12: «PMID: 35884749»PubMed